Ryman Healthcare Stock Forecast for 2023 - 2025 - 2030
Updated on 04/24/2024
Ryman Healthcare Stock Forecast and Price Target
Year-long price target forecasts from two prominent analysts have recently been released for Ryman Healthcare, with an average price target of $7.30. This potential gain of 72.58 percent from the previous closing price in April, 2024 is calculated on a high forecast of $9.60 and a low estimate of $5.29. If you are interested in RYM stock, it is important to also consider its competitors.
72.58% Upside
Ryman Healthcare Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Ryman Healthcare's Price has decreased from $9.12 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $8.74 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FSLR Stock Forecast | First Solar | Outperform |
11
|
$180.10 | Buy/Sell | $232.38 | 26.04% |
| LLC Stock Forecast | Lendlease Group | Hold |
12
|
$6.51 | Buy/Sell | $8.92 | 11.37% |
| AGRO Stock Forecast | Ros Agro PLC | - |
18
|
$7.10 | Buy/Sell | $0.00 | -100.00% |
| ARV Stock Forecast | Arvida Group | Outperform |
16
|
$1.05 | Buy/Sell | $1.44 | 36.19% |
| 8022 Stock Forecast | Mizuno | Underperform |
14
|
¥5.22k | Buy/Sell | ¥0.00 | -10.34% |
Ryman Healthcare Revenue Forecast for 2023 - 2025 - 2030
Ryman Healthcare's Revenue has seen impressive growth In the last three years, rising from $423.34M to $568.84M – a growth of 34.37%. In the next year, analysts believe that Revenue will reach $716.98M – an increase of 26.04%. For the next six years, the forecast is for Revenue to grow by 24.20%.
.jpg)
Ryman Healthcare Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Ryman Healthcare's Dividend per Share has decreased by 62.50%, going from $0.24 to $0.09. 4 analysts predict Ryman Healthcare's Dividend per Share will decrease by 100.00% in the next year, reaching $0.00. Over the next six years, experts believe that Ryman Healthcare's Dividend per Share will grow at a rate of 66.67%.
Ryman Healthcare EBITDA Forecast for 2023 - 2025 - 2030
Ryman Healthcare's EBITDA has decreased by 70.24% In the last three years, from $68.69M to $20.44M. Analysts predict that Ryman Healthcare's EBITDA will increase in the upcoming year, reaching $521.50M. This would represent an increase of 2451.37%. Over the next six years, experts predict that Ryman Healthcare's EBITDA will grow at a rate of 5790.41%.
Ryman Healthcare EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Ryman Healthcare's EBIT has decreased from $45.47M to $-11.04M – a 124.28% drop! The next year, 4 experts forecast that Ryman Healthcare's EBIT will decrease by 3351.99%, reaching $359.02M. In 2030, professionals predict that Ryman Healthcare's EBIT will decrease by 4456.88%, reaching $481.00M.
Ryman Healthcare EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Ryman Healthcare's EPS has decreased from $0.48 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $0.46 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
.jpg)